As more patients begin GLP-1 therapy, pharmacists play a critical role in helping them manage side effects, stay adherent, and achieve better outcomes
After propensity matching for age, sex, race, and obesity, 69,221 patients were included in the primary analysis
via G-protein-coupled receptors, nuclear farnesoid-receptor X and the G-protein-coupled bile acid-activated receptor [TGR5]) are currently being explored in experimental studies
Kate Wolin Resources: [2] [3] [4] [5] [6] Longevity by Design is a podcast for individuals looking to experience longer, healthier lives
In addition to suppressing appetite, semaglutide offers significant benefits, such as improved blood sugar control, reduced risk of cardiovascular disease, and potential improvements in metabolic health